Kent Wanzek - Fresenius Medical CEO

FMCQF Stock  USD 36.95  0.00  0.00%   

CEO

Mr. Kent Wanzek was Member of the Management Board, Chief Executive Officer for Global Manufacturing and Quality at Fresenius Medical Care AG Co. KGaA since January 1, 2010. From 2004 onwards, he was in charge of North American operations for the Renal Therapies Group at Fresenius Medical Care North America. Prior to joining the Company in 2003, he held several senior executive positions at Philips Medical Systems, Perkin Elmer and Baxter Healthcare Corporationrationration, among others. since 2010.
Age 58
Tenure 14 years
Phone49 6172 608 2522
Webhttps://www.freseniusmedicalcare.com

Fresenius Medical Management Efficiency

The company has return on total asset (ROA) of 0.0253 % which means that it generated a profit of $0.0253 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0666 %, meaning that it generated $0.0666 on every $100 dollars invested by stockholders. Fresenius Medical's management efficiency ratios could be used to measure how well Fresenius Medical manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 6.65 B in total debt with debt to equity ratio (D/E) of 0.82, which is about average as compared to similar companies. Fresenius Medical Care has a current ratio of 1.31, which is within standard range for the sector. Debt can assist Fresenius Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Fresenius Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Fresenius Medical Care sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Fresenius to invest in growth at high rates of return. When we think about Fresenius Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 8 records

CEO Age

Stephen FlattNational HealthCare
68
Christopher ChristensenThe Ensign Group
55
David ChernowSelect Medical Holdings
67
Mark TarrEncompass Health Corp
62
Bassam DamajInnovAge Holding Corp
47
April AnthonyEncompass Health Corp
53
Debra OsteenAcadia Healthcare
62
Patrick BlairInnovAge Holding Corp
53
KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Med is traded on OTC Exchange in the United States. Fresenius Medical Care [FMCQF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Fresenius Medical Care Leadership Team

Elected by the shareholders, the Fresenius Medical's board of directors comprises two types of representatives: Fresenius Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fresenius. The board's role is to monitor Fresenius Medical's management team and ensure that shareholders' interests are well served. Fresenius Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fresenius Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Oliver Maier, Senior Vice President of Investor Relations
Roberto Fuste, Member of the Management Board for Asia-Pacific
Walter Weisman, Member of the Supervisory Board
Michael Brosnan, CFO of Fresenius Medical Care Management AG and Member of the Management Board - Fresenius Medical Care Management AG
Pascale Witz, Member of the Supervisory Board
Katarzyna MazurHofsab, Management AG
Borries Muller, VP Communications
Kent Wanzek, Member of the Management Board - Fresenius Medical Care Management AG and CEO of Global Manufacturing and Quality - Fresenius Medical Care Management AG
Joachim Weith, Sr Affairs
Deborah McWhinney, Member of the Supervisory Board
Robert Powell, Chairman Board
Franklin FACP, Global AG
Dieter Schenk, Vice Chairman of the Supervisory Board
Katarzyna MazurHofsaess, Member of the Management Board
Ronald Kuerbitz, Member of the Management Board - Fresenius Medical Care Management AG and CEO of Fresenius Medical Care North America - Fresenius Medical Care Management AG
Dominik Wehner, Member of the Management Board for Europe, Middle East and Africa
Gregor Zuend, Member of the Supervisory Board
Rolf Classon, Member of the Supervisory Board
Helen Giza, Chief CEO
Ben Lipps, Honorary Chairman
Gregor Zund, Member of the Supervisory Board
Bernd Fahrholz, Member of the Supervisory Board
Nwamaka MD, Head Operations
William Johnston, Member of the Supervisory Board
Olaf Schermeier, Member of the Management Board for Global Research & Development
Dominik Heger, Head of Investor Relations & Corporate Communications
Frank Maddux, Chief Medical Officer
William Valle, CEO for North America, Member of the Management Board
Rice Powell, Chairman of the Management Board, CEO
Harry Wit, Member of the Management Board, CEO for Asia-Pacific
Carla Kriwet, CEO Care
Gerd Krick, Chairman of the Supervisory Board

Fresenius Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Fresenius Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Fresenius Medical Care is a strong investment it is important to analyze Fresenius Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fresenius Medical's future performance. For an informed investment choice regarding Fresenius Pink Sheet, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Fresenius Pink Sheet analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bonds Directory
Find actively traded corporate debentures issued by US companies
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Correlations
Find global opportunities by holding instruments from different markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Please note, there is a significant difference between Fresenius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.